Cargando…

The Proliferative Role of Immune Checkpoints in Tumors: Double Regulation

SIMPLE SUMMARY: Cancer remains a serious health problem owing to its high morbidity and mortality. Immunotherapy, represented by anti-programmed death-1D1/anti-PD-Ligand 1 treatments, has become one of the most important methods for cancer treatment. However, there are still some challenges in this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Xi-Yang, Luo, Zhong-Lin, Xiong, Yan-Lu, Yang, Jie, Shi, An-Ping, Zheng, Kai-Fu, Liu, Yu-Jian, Shu, Chen, Ma, Nan, Lu, Qiang, Zhao, Jin-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9657406/ https://www.ncbi.nlm.nih.gov/pubmed/36358792 http://dx.doi.org/10.3390/cancers14215374

Ejemplares similares

Dual immunological and proliferative regulation of immune checkpoint FGL1 in lung adenocarcinoma: The pivotal role of the YY1–FGL1–MYH9 axis
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Clinical Research on the Mechanisms Underlying Immune Checkpoints and Tumor Metastasis
por: Tang, Xi-Yang, et al.
Publicado: (2021)

Immune Checkpoint LAG3 and Its Ligand FGL1 in Cancer
por: Shi, An-Ping, et al.
Publicado: (2022)

IGSF11 and VISTA: a pair of promising immune checkpoints in tumor immunotherapy
por: Tang, Xi-Yang, et al.
Publicado: (2022)

Proliferative potential and resistance to immune checkpoint blockade in lung cancer patients
por: Pabla, Sarabjot, et al.
Publicado: (2019)

Intraparticle Double‐Scattering‐Decoded Sonogenetics for Augmenting Immune Checkpoint Blockade and CAR‐T Therapy
por: Wang, Duo, et al.
Publicado: (2022)

Resveratrol antagonizes thyroid hormone-induced expression of checkpoint and proliferative genes in oral cancer cells
por: Lin, Chia-Cheng, et al.
Publicado: (2019)

Plasma metabolomic profiling of proliferative diabetic retinopathy
por: Zhu, Xiao-Rong, et al.
Publicado: (2019)

The Effect of Smoking on the Immune Microenvironment and Immunogenicity and Its Relationship With the Prognosis of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer
por: Sun, Yueqin, et al.
Publicado: (2021)

The Potential of Five Immune-Related Prognostic Genes to Predict Survival and Response to Immune Checkpoint Inhibitors for Soft Tissue Sarcomas Based on Multi-Omic Study
por: Gu, Hui-Yun, et al.
Publicado: (2020)

Importance of optimizing duration of adjuvant immune checkpoint inhibitor therapy to treat postoperative hepatocellular carcinoma after conversion therapy: a case report
por: Li, Jian-Rong, et al.
Publicado: (2023)

Neoadjuvant Chemotherapy Improves the Immunosuppressive Microenvironment of Bladder Cancer and Increases the Sensitivity to Immune Checkpoint Blockade
por: Luo, Hao, et al.
Publicado: (2022)

PD-L1 expression and immune cells infiltration in primary tracheobronchial neoplasm
por: Zheng, Kai-Fu, et al.
Publicado: (2021)

Predictive Biomarkers of Immune Checkpoint Inhibitors-Related Toxicities
por: Xu, Ya, et al.
Publicado: (2020)

RB1 aberrations predict outcomes of immune checkpoint inhibitor combination therapy in NSCLC
por: Wang, Qian, et al.
Publicado: (2023)

Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications
por: Fang, Jianwen, et al.
Publicado: (2023)

Proliferative Tumor Doubling Times of Prostatic Carcinoma
por: Werahera, Priya N., et al.
Publicado: (2011)

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma
por: Huang, Jin-Tao, et al.
Publicado: (2022)

Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated anti-tumor immunity
por: Liu, Longchao, et al.
Publicado: (2022)

Checkpoint CD47 Function On Tumor Metastasis And Immune Therapy
por: Lian, Shu, et al.
Publicado: (2019)

Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition
por: Zheng, Guoxing, et al.
Publicado: (2023)

Identification of immune associated potential molecular targets in proliferative diabetic retinopathy
por: Gao, Ying, et al.
Publicado: (2023)

Risk factors for cardiovascular adverse events from immune checkpoint inhibitors
por: Luo, Lingli, et al.
Publicado: (2023)

Immune Checkpoints in Viral Infections
por: Cai, Huiming, et al.
Publicado: (2020)

EPHA7 mutation as a predictive biomarker for immune checkpoint inhibitors in multiple cancers
por: Zhang, Zhen, et al.
Publicado: (2021)

The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors
por: Jia, Xiao-Hui, et al.
Publicado: (2020)

Landscape of immune checkpoint inhibitor-related adverse events in Chinese population
por: Li, Li, et al.
Publicado: (2020)

Myocarditis Induced by Immune Checkpoint Inhibitors: Mechanisms and Therapeutic Prospects
por: Zou, Wenlu, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Special Populations
por: Shan, Qianyun, et al.
Publicado: (2021)

Immune Checkpoint Inhibitor-related Endocrinopathies
por: Lu, Difei, et al.
Publicado: (2022)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Jiang, Ben‐Yuan, et al.
Publicado: (2021)

Analysis of combination therapy of immune checkpoint inhibitors in osteosarcoma
por: Peng, Lijun, et al.
Publicado: (2022)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Identification of four immune subtypes in locally advanced rectal cancer treated with neoadjuvant chemotherapy for predicting the efficacy of subsequent immune checkpoint blockade
por: He, Le, et al.
Publicado: (2022)

The Current status of steroid-refractory immune-checkpoint-inhibitor-related hepatotoxicity
por: Xing, Hui, et al.
Publicado: (2023)

Immune Checkpoint Protein Expression Defines the Prognosis of Advanced Thyroid Carcinoma
por: Luo, Yi, et al.
Publicado: (2022)

The promising immune checkpoint LAG-3 in cancer immunotherapy: from basic research to clinical application
por: Huo, Jin-Ling, et al.
Publicado: (2022)

Fucoidan-Supplemented Diet Potentiates Immune Checkpoint Blockage by Enhancing Antitumor Immunity
por: Yang, Juan, et al.
Publicado: (2021)

mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers
por: Cheng, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_o18g7rbu8he7ed6nio173ohp3j